Hospice News May 6, 2021
LHC Group (NASDAQ: LHCG) aims to continue growth of its hospice services as this year unfolds with a number of acquisitions in the works. Record-high multiples for hospice acquisitions are not deterring LHC Group from pursuing those transactions. Hospice deals accounted for 71% of the $502.5 million the company currently earmarked for its M&A pipeline.
The home health and hospice provider will remain active this year and expects to deliver or exceed its target of $150 to $200 million in acquired annual revenue, according to Keith Meyers, LHC Group’s chairman and CEO, with “several exclusive deals in various stages in negotiations.” The company pushed through pandemic-related headwinds in March and April, giving them “strong confidence to be very bullish on...